149 related articles for article (PubMed ID: 34619736)
1. Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix.
Paterniti TA; Dorr K; Ullah A; White J; Williams H; Ghamande S
Obstet Gynecol; 2021 Nov; 138(5):813-816. PubMed ID: 34619736
[TBL] [Abstract][Full Text] [Related]
2. Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
Brahmer JR; Lee JS; Ciuleanu TE; Bernabe Caro R; Nishio M; Urban L; Audigier-Valette C; Lupinacci L; Sangha R; Pluzanski A; Burgers J; Mahave M; Ahmed S; Schoenfeld AJ; Paz-Ares LG; Reck M; Borghaei H; O'Byrne KJ; Gupta RG; Bushong J; Li L; Blum SI; Eccles LJ; Ramalingam SS
J Clin Oncol; 2023 Feb; 41(6):1200-1212. PubMed ID: 36223558
[TBL] [Abstract][Full Text] [Related]
3. Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.
McDonald MA; Sanghvi P; Bykowski J; Daniels GA
BMC Cancer; 2018 May; 18(1):549. PubMed ID: 29743050
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.
Frumovitz M; Munsell MF; Burzawa JK; Byers LA; Ramalingam P; Brown J; Coleman RL
Gynecol Oncol; 2017 Jan; 144(1):46-50. PubMed ID: 27823771
[TBL] [Abstract][Full Text] [Related]
5. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
[TBL] [Abstract][Full Text] [Related]
6. Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma.
Towner M; Novak K; Chae YK; Matei D
Gynecol Oncol Rep; 2022 Aug; 42():101039. PubMed ID: 35846558
[TBL] [Abstract][Full Text] [Related]
7. Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinoma.
George G; Schmidt L; Tolat P; Riese M; Kilari D
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32114501
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine carcinoma of the cervix: a systematic review of the literature.
Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA
BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
10. Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy.
Embry JR; Kelly MG; Post MD; Spillman MA
Gynecol Oncol; 2011 Mar; 120(3):444-8. PubMed ID: 21138780
[TBL] [Abstract][Full Text] [Related]
11. First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1.
Reck M; Ciuleanu TE; Lee JS; Schenker M; Audigier-Valette C; Zurawski B; Linardou H; Otterson GA; Salman P; Nishio M; de la Mora Jimenez E; Lesniewski-Kmak K; Albert I; Ahmed S; Syrigos K; Penrod JR; Yuan Y; Blum SI; Nathan FE; Sun X; Moreno-Koehler A; Taylor F; O'Byrne KJ
J Thorac Oncol; 2021 Apr; 16(4):665-676. PubMed ID: 33485960
[TBL] [Abstract][Full Text] [Related]
12. [A case of large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix successfully treated by postoperative CPT-11+CDDP chemotherapy after non-curative surgery].
Tanimoto H; Hamasaki A; Akimoto Y; Honda H; Takao Y; Okamoto K; Teramoto M; Teramoto H; Kaneko M; Oshita T
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1439-41. PubMed ID: 22996787
[TBL] [Abstract][Full Text] [Related]
13. Large cell neuroendocrine carcinoma of the uterine cervix.
Habeeb A; Habeeb H
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30642849
[TBL] [Abstract][Full Text] [Related]
14. Carcinomatous meningitis during systematic chemotherapy in a patient with advanced small-cell neuroendocrine carcinoma of the uterine cervix.
Watanabe Y; Nakai H; Imaoka I; Murakami T; Hoshiai H
J Obstet Gynaecol Res; 2012 Jan; 38(1):336-9. PubMed ID: 21917069
[TBL] [Abstract][Full Text] [Related]
15. Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Wong JSL; Kwok GGW; Tang V; Li BCW; Leung R; Chiu J; Ma KW; She WH; Tsang J; Lo CM; Cheung TT; Yau T
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563773
[TBL] [Abstract][Full Text] [Related]
16. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy in stage IB neuroendocrine small cell carcinoma of the cervix.
Abulafia O; Sherer DM
Acta Obstet Gynecol Scand; 1995 Oct; 74(9):740-4. PubMed ID: 7572111
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms.
Al-Toubah T; Halfdanarson T; Gile J; Morse B; Sommerer K; Strosberg J
ESMO Open; 2022 Feb; 7(1):100364. PubMed ID: 34973511
[TBL] [Abstract][Full Text] [Related]
19. A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).
Meindl-Beinker NM; Betge J; Gutting T; Burgermeister E; Belle S; Zhan T; Schulte N; Maenz M; Ebert MP; Haertel N
BMC Cancer; 2019 Mar; 19(1):231. PubMed ID: 30871493
[TBL] [Abstract][Full Text] [Related]
20. Durable Response to Carboplatin, Etoposide, Nivolumab, and Ipilimumab in Metastatic High-Grade Neuroendocrine Carcinoma of the Gallbladder.
Chorath J; Placencio-Hickok VR; Guan M; Nissen N; Kamrava M; Klempner SJ; Nassir Y; Hendifar A; Gong J
Pancreas; 2020 Feb; 49(2):e19-e20. PubMed ID: 32049953
[No Abstract] [Full Text] [Related]
[Next] [New Search]